Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Drug Interaction Checker + is an established medical app that is available. With a 4.1/5 rating from 66 reviews, it shows polarized user reception. Users particularly appreciate pharmacists and medical students value the accurate drug interaction checker for clinical reference, though aggressive paywall implementation prevents access to core interaction features after initial data entry remains a common concern.

What is Drug Interaction Checker +?

Drug Interaction Checker + is a mobile medical reference tool providing pharmacological data, pill identification, and interaction checking for healthcare professionals and patients.

Users hire this app for rapid, verified clinical decision support that fits into a mobile workflow, replacing bulky desktop references.

Current Momentum

v14 · 65mo ago

Zombie
  • Ships database updates for clinical accuracy.
  • Maintains niche international grossing presence.

Active Nemesis

Drugs.com Medication Guide

Drugs.com Medication Guide

By Drugs.com

Other Rivals

Medisafe Medication Management
GoodRx: Prescription Savings
AMBOSS Medical Knowledge
WebMD: Symptom Checker
Medscape
Full Code Medical Simulation

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

Rating Pulse 🇺🇸

Recent User Mood

What makes this app unique?

What Does It Look Like?

Loading...

What Are The Key Features?

Drug Interaction CheckerDifferentiator

Cross-references a user-input list of medications to identify potential adverse events or efficacy issues

Pill IdentifierDifferentiator

Matches pill images and physical characteristics like imprint, shape, and color to specific drug names

Drug MonographsStandard

Provides detailed pharmacology, dosage, contraindications, and clinical trial results for individual drugs

How much does it cost?

Subscription
  • Free tier with limited access
  • Premium subscription at $9.99/month or $49.99/year

Subscription model anchored at $9.99/month, gating core clinical tools behind a paywall.

Who Built It?

What do users think recently?

Low confidence · 17 reviews analyzed

How did the latest release land?

Overall
4.1/ 5
(66)
Current version
4.1/ 5
0.0 vs overall
(66)
Main signal post-update: pharmacists and medical students value the accurate drug interaction checker for clinical reference.

What is the recent mood?

Mixed

Recent user voice shows a mixed sentiment. Users appreciate pharmacists and medical students value the accurate drug interaction checker for clinical reference and quick navigation and diverse search options facilitate efficient drug information retrieval for users, but report aggressive paywall implementation prevents access to core interaction features after initial data entry and subscription management and cancellation processes are opaque and difficult to navigate post-update.

Limited review volume (17 reviews). Sentiment analysis will deepen as more data lands.

How have ratings & review volume moved?

Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.

Rating over time

Vertical markers = app releases. Hover any release for the post-release impact delta.

View the full user-sentiment analysis

Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.

Go deeper

What is the competitive landscape for Drug Interaction Checker +?

How's The Medical Market?

How does it evolve in the Medical market?

The app maintains niche grossing positions in international markets (e.g., #49 in RO), but high rank volatility suggests the current subscription-gated model struggles to sustain long-term user retention.

Rank progression

28 active rankings tracked — 30-day window

Which niche is Drug Interaction Checker + in?

Pharmacology Guides

to identify drug interactions and medical information

GuidePharmacologyProfessionalsSubscriptionEmerging

Explore the full Pharmacology Guides niche

Every app in this space — 6 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.

Go deeper

The rivals identified

Nemeses(1)

This is the definitive market leader for drug reference and interaction checking, maintaining a massive, authoritative database that serves as the industry standard.

Differentiators

  • Maintains a comprehensive, professionally curated drug database that is widely considered the gold standard for accuracy.
  • Integrates advanced pill identification tools directly into the core medication guide experience for seamless cross-referencing.
  • Provides deep clinical pharmacology data that exceeds the basic summary information found in smaller reference tools.

Head to head

The target app must pivot toward a specialized, high-speed UX to differentiate from the encyclopedic, data-heavy dominance of the Drugs.com platform.

Contenders(3)

Targets the professional medical student and physician demographic with high-fidelity, peer-reviewed clinical content.

Differentiators

  • Provides a highly structured, exam-focused knowledge base designed specifically for medical education and clinical decision support.
  • Features a sophisticated, cross-referenced content architecture that allows users to navigate complex medical topics with high precision.

Captures the financial utility segment of the medical market with massive scale and aggressive feature shipping.

Differentiators

  • Integrates real-time pharmacy pricing and coupon generation, creating a transactional utility that drives daily active usage.
  • Maintains an aggressive release schedule, shipping frequent updates to optimize the user's path to prescription savings.

Dominates the medication adherence space with a massive user base and high-frequency release cadence.

Differentiators

  • Focuses on behavioral adherence through personalized reminders and family-sharing features rather than just static drug reference data.
  • Implements a high-frequency update cycle that keeps the app relevant with modern OS features and user engagement loops.

Same space(2)

Medscape icon
Medscapemoat: medium

WebMD

3.7(63.9K)

A professional-grade medical reference tool that serves as a direct alternative for clinical drug information.

Differentiators

  • Provides clinical news and continuing medical education (CME) credits, catering specifically to the professional healthcare provider audience.
  • Includes a robust clinical calculator suite that adds significant utility beyond simple drug interaction checking.
WebMD: Symptom Checker icon

WebMD

4.7(133.9K)

A broad-spectrum medical resource that captures the general consumer audience through symptom-based search intent.

Differentiators

  • Utilizes a symptom-checker engine to drive top-of-funnel traffic, which is a different entry point than a direct drug reference tool.
  • Offers a massive library of general health content that keeps users within the ecosystem for non-medication-related queries.

New entrants(1)

Full Code Medical Simulation icon

Full Code Medical Inc.

4.1(6.7K)

An emerging threat in the medical education space, focusing on gamified clinical simulation rather than static reference.

Differentiators

  • Uses interactive, gamified clinical scenarios to teach pharmacology and decision-making, moving beyond passive reference reading.
  • Prioritizes active learning loops that increase time-in-app compared to traditional, static drug reference tools.

Compare Drug Interaction Checker + against every rival

All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.

Go deeper

The outtake for Drug Interaction Checker +

Strengths to defend, gaps to attack

Core Strengths

  • High-accuracy interaction checker provides reliable clinical utility
  • Lightweight interface enables faster lookups than encyclopedic rivals

Critical Frictions

  • Aggressive paywalling post-data entry drives negative sentiment
  • Opaque subscription cancellation process increases churn
  • Incomplete herbal remedy database limits utility

Growth Levers

  • Expand database to include herbal remedies to capture wellness audience
  • Implement limited free-tier interaction check to improve conversion

Market Threats

  • Drugs.com's free, comprehensive database model
  • Increasing user sensitivity to subscription-gated medical information
  • Volatility in international grossing ranks

What are the next best moves?

highPivot

Implement a limited free-tier interaction check because paywalling post-data entry is the #1 complaint → increase conversion trust.

Sentiment analysis identifies aggressive paywalling as the primary driver of negative reviews.

Trade-off: Pause the database expansion for herbal remedies — fixing the conversion funnel is a higher revenue priority.

mediumMaintain

Audit subscription management links because users report difficulty canceling trials → reduce churn and support overhead.

User complaints highlight opaque cancellation processes as a major frustration point.

Trade-off: Same-quarter capacity available — no major lever displaced.

A counter-intuitive read

The app's biggest threat is not a feature-rich rival, but the 'free-by-default' expectation of medical data that makes any paywalling of basic interaction checks a structural conversion failure.

Feature Gaps vs Competitors

  • Comprehensive herbal remedy database (available in Drugs.com but missing here)
  • Clinical calculator suite (available in Medscape but missing here)

Key Takeaways

The app provides high-accuracy clinical data that professionals value, but the aggressive paywalling of core features drives significant user frustration, so the PM should pivot to a more transparent freemium model to stabilize retention.

Where Is It Heading?

Declining

The medical reference market is consolidating around free, comprehensive databases, leaving niche apps with restrictive paywalls exposed to high churn. The subject app must pivot its monetization strategy to prioritize user trust over immediate conversion to avoid further rank erosion.

Aggressive paywalling post-data entry triggers high-frequency churn complaints, which erodes the long-term user base and damages brand reputation.

The lack of herbal remedy data creates a functional gap that limits the app's utility for comprehensive medication reviews.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Drug Interaction Checker +, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The analysis transitioned from a high-level maintenance assessment to a granular critique of the app's conversion funnel, identifying aggressive paywalling as the primary driver of user churn.

added

User Sentiment Data

added

Competitive Landscape

added

New Weaknesses and Threats

shifted

Strategic Focus

Cite this report

Marlvel.ai. “Drug Interaction Checker + Intelligence Report.” Updated May 26, 2026. https://marlvel.ai/apps/drug-interaction-checker

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0